Received Sep 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | TFAA2504 | OT / LA |
felt that it was very moist, with more than just blood; Initial information received on 08-Sep-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 63 years old female patient who had felt that it was very moist, with more than just blood after receiving Influenza Trivalent Recombinant Vaccine [flublok TIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included covid-19 vaccine or Immunisation. On 07-Sep-2025, the patient received unknown dose of suspect influenza trivalent recombinant vaccine Solution for injection of standard strength, frequency once with lot TFAA2504 and expiry date 30-APR-2026 via intramuscular route in the left deltoid for Influenza. On 07-Sep-2025 the patient developed a non-serious felt that it was very moist, with more than just blood (vaccination site haemorrhage) (Latency same day) following the administration of influenza trivalent recombinant vaccine. Reportedly, The reporter stated that this weekend one of their interns administered flublok to a customer. The customer went home and took off the bandage and she felt that it was very moist, with more than just blood. The pharmacist spoke to the intern, and the intern said that nothing went wrong when he administered it. All of the liquid went in, and it was administered correctly. The needle was screwed onto the syringe properly and the syringe was put all the way in. There was no issue with the flublok syringe. Action taken was not applicable. It was not reported if the patient received corrective treatment for the event. At time of reporting, the outcome was Unknown for the event.
COVID-19 VACCINE